Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/10760296211021498 http://scihub22266oqcxt.onion/10.1177/10760296211021498 34060379!8173993!34060379     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Appl+Thromb+Hemost 2021 ; 27 (ä): 10760296211021498 Nephropedia Template TP {{tp|p=34060379|t=2021. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination |pdf=|usr=}}{{34060379}} gab.com Text An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination JO: Clin Appl Thromb Hemost http://www.kidney.de/pget.php?&tw=1&pmid=34060379 #FOAvip Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem. After more than a year with the pandemic, although our knowledge has progressed on COVID-19, there are still many unknowns in virological, pathophysiological and immunological aspects. It is obvious that the most efficient solution to end this pandemic are safe and efficient vaccines. This manuscript summarizes the pathophysiological and thrombotic features of COVID-19 and the safety and efficacy of currently approved COVID-19 vaccines with an aim to clarify the recent concerns of thromboembolic events after COVID-19 vaccination. The influx of newer information is rapid, requiring periodic updates and objective assessment of the data on the pathogenesis of COVID-19 variants and the safety and efficacy of currently available vaccines. Twit Text FOAVip An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination ????Clin Appl Thromb Hemost http://www.kidney.de/pget.php?&tw=1&pmid=34060379 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34060379 #FOAvip English Wikipedia <ref>{{Cite pmid|34060379}}</ref> An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination #MMPMID34060379 Kantarcioglu B; Iqbal O; Walenga JM; Lewis B; Lewis J; Carter CA; Singh M; Lievano F; Tafur A; Ramacciotti E; Gerotziafas GT; Jeske W; Fareed J Clin Appl Thromb Hemost 2021[Jan]; 27 (ä): 10760296211021498 PMID34060379show ga Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem. After more than a year with the pandemic, although our knowledge has progressed on COVID-19, there are still many unknowns in virological, pathophysiological and immunological aspects. It is obvious that the most efficient solution to end this pandemic are safe and efficient vaccines. This manuscript summarizes the pathophysiological and thrombotic features of COVID-19 and the safety and efficacy of currently approved COVID-19 vaccines with an aim to clarify the recent concerns of thromboembolic events after COVID-19 vaccination. The influx of newer information is rapid, requiring periodic updates and objective assessment of the data on the pathogenesis of COVID-19 variants and the safety and efficacy of currently available vaccines. |*SARS-CoV-2/genetics/immunology/pathogenicity[MESH] |Ad26COVS1[MESH] |Autoantibodies/biosynthesis[MESH] |BNT162 Vaccine[MESH] |COVID-19 Vaccines/*adverse effects/genetics/immunology[MESH] |COVID-19/epidemiology/physiopathology/*prevention & control[MESH] |ChAdOx1 nCoV-19[MESH] |Clinical Trials as Topic[MESH] |Disseminated Intravascular Coagulation/epidemiology/etiology[MESH] |Drug Approval[MESH] |Female[MESH] |Genetic Vectors[MESH] |Glycosaminoglycans/immunology[MESH] |Humans[MESH] |Male[MESH] |Models, Cardiovascular[MESH] |Pandemics/prevention & control[MESH] |Platelet Factor 4/immunology[MESH] |Safety[MESH] |Sinus Thrombosis, Intracranial/epidemiology/etiology[MESH] |Thrombosis/epidemiology/*etiology/physiopathology[MESH] |Vaccines, Inactivated/adverse effects/genetics/immunology[MESH] |Vaccines, Synthetic/adverse effects/genetics/immunology[MESH]An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thro(epmc).pdf DeepDyve Pubget Overpricing